Huawei Songshanhu Base Tour: How Does IPR Strategy Portfolio Drive Innovation and Commercial Benefits? Go back »
Click here to view pictures of this event.
-
Time2019-05-08 | 14:00 - 16:00
-
Venue:Huawei Songshanhu Base
-
Address:
-
Fee:Members: 350 |
Non Members: 650
Download event materials
We kindly request that all attendees complete a quick feedback form before downloading.
| Technology Transfer and Common Considerations - 8 May 19.pdf Attendees only |
| Innovation and IP of Huawei--TO EUCCC.pdf Attendees only |
| See more downloads » |
As of December 31, 2018, Huawei's total number of granted patents reached 87,805. Among them, 11,152 core patents were granted in the United States..
Huawei’s R&D expenses totalled CNY 101.5 billion in 2018, accounting for 14.1% of the company’s annual revenue. Huawei has cumulatively spent more than CNY 485 billion on R&D over the last decade.
Downloads
Speakers
Mr. Handong RAN
Handong joined Maucher Jenkins (then RGC Jenkins & Co.) in 2006 and became a partner in 2013. Before joining Maucher Jenkins, Handong worked as an IT analyst at IBM and as a research assistant in a cancer research lab in London. At Maucher Jenkins, Handong has looked after European patent portfolios for several multinational clients in the fields of telecommunications and computing technologies and also assisted a number of SMEs to secure patent rights for their inventions. Handong moved to China at the end of 2011 to set up a Beijing Office for Maucher Jenkins and has gradually expanded the firm’s presence in China to Shenzhen and Nanjing. While continuing to handle European and UK patent matters in China, Handong has also advised a number of international clients on Chinese patent and trademark issues and technology transfer projects. Handong became a member of International Liaison Committee at the Chartered Institute of Patent Attorneys since 2016, with a specific focus on the Greater China Region.